Kyung Nam Pharm Co.,Ltd. (KOSDAQ: 053950)
South Korea
· Delayed Price · Currency is KRW 769.00
-1.00 (-0.13%)
Dec 19, 2024, 1:59 PM KST
Kyung Nam Pharm Co.,Ltd. Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 69,432 | 68,445 | 59,000 | 64,623 | 70,933 | 44,806 | Upgrade
|
| Other Revenue | - | -0 | - | - | -0 | - | Upgrade
|
| Revenue | 69,432 | 68,445 | 59,000 | 64,623 | 70,933 | 44,806 | Upgrade
|
| Revenue Growth (YoY) | 18.88% | 16.01% | -8.70% | -8.89% | 58.31% | 8.14% | Upgrade
|
| Cost of Revenue | 51,033 | 47,449 | 42,632 | 43,614 | 42,258 | 28,006 | Upgrade
|
| Gross Profit | 18,398 | 20,996 | 16,368 | 21,010 | 28,674 | 16,800 | Upgrade
|
| Selling, General & Admin | 22,029 | 25,561 | 19,039 | 27,773 | 25,077 | 19,031 | Upgrade
|
| Research & Development | 1 | 1 | - | - | - | - | Upgrade
|
| Other Operating Expenses | 476.75 | 443.87 | 194.83 | 172.11 | 144.78 | 228.21 | Upgrade
|
| Operating Expenses | 24,016 | 27,709 | 19,779 | 29,765 | 26,098 | 20,132 | Upgrade
|
| Operating Income | -5,618 | -6,712 | -3,411 | -8,756 | 2,576 | -3,332 | Upgrade
|
| Interest Expense | -3,677 | -2,672 | -1,952 | -1,580 | -1,205 | -323.43 | Upgrade
|
| Interest & Investment Income | 962.48 | 825.47 | 529.74 | 86.44 | 170.13 | 280.61 | Upgrade
|
| Earnings From Equity Investments | -122.1 | -281.96 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -80.09 | 9.12 | 26.25 | 178.52 | -104.43 | -4.98 | Upgrade
|
| Other Non Operating Income (Expenses) | 3,164 | -200.64 | -1,544 | 8,825 | -9,528 | -946.82 | Upgrade
|
| EBT Excluding Unusual Items | -5,370 | -9,033 | -6,350 | -1,246 | -8,091 | -4,327 | Upgrade
|
| Impairment of Goodwill | -10,843 | -10,843 | -139.69 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -1,760 | 365.81 | 1,669 | -2,789 | 1,014 | 5.13 | Upgrade
|
| Gain (Loss) on Sale of Assets | -418.17 | -576.7 | -204.32 | -39.9 | -17.83 | -98.32 | Upgrade
|
| Asset Writedown | -281.81 | -972.36 | -2,370 | 775.97 | -105.56 | -1,788 | Upgrade
|
| Other Unusual Items | 397.54 | - | - | - | 60.82 | - | Upgrade
|
| Pretax Income | -18,276 | -21,059 | -7,395 | -3,299 | -7,139 | -6,208 | Upgrade
|
| Income Tax Expense | 1,297 | 1,169 | 433.58 | -90.44 | -2,004 | -1,661 | Upgrade
|
| Earnings From Continuing Operations | -19,573 | -22,228 | -7,828 | -3,209 | -5,135 | -4,546 | Upgrade
|
| Earnings From Discontinued Operations | 15,220 | - | - | -204.51 | -352.81 | - | Upgrade
|
| Net Income to Company | -4,353 | -22,228 | -7,828 | -3,413 | -5,488 | -4,546 | Upgrade
|
| Minority Interest in Earnings | 1,132 | 1,231 | - | - | - | - | Upgrade
|
| Net Income | -3,221 | -20,997 | -7,828 | -3,413 | -5,488 | -4,546 | Upgrade
|
| Net Income to Common | -3,221 | -20,997 | -7,828 | -3,413 | -5,488 | -4,546 | Upgrade
|
| Shares Outstanding (Basic) | 36 | 35 | 29 | 21 | 17 | 16 | Upgrade
|
| Shares Outstanding (Diluted) | 36 | 35 | 29 | 23 | 17 | 16 | Upgrade
|
| Shares Change (YoY) | 3.66% | 21.50% | 27.71% | 32.46% | 11.06% | 36.39% | Upgrade
|
| EPS (Basic) | -90.54 | -592.28 | -268.29 | -159.71 | -318.17 | -292.75 | Upgrade
|
| EPS (Diluted) | -90.54 | -593.00 | -268.29 | -367.60 | -318.46 | -293.00 | Upgrade
|
| Free Cash Flow | -6,557 | -16,130 | -2,780 | -11,648 | -42,966 | -7,748 | Upgrade
|
| Free Cash Flow Per Share | -184.31 | -454.99 | -95.26 | -509.84 | -2491.14 | -498.93 | Upgrade
|
| Gross Margin | 26.50% | 30.68% | 27.74% | 32.51% | 40.42% | 37.50% | Upgrade
|
| Operating Margin | -8.09% | -9.81% | -5.78% | -13.55% | 3.63% | -7.44% | Upgrade
|
| Profit Margin | -4.64% | -30.68% | -13.27% | -5.28% | -7.74% | -10.15% | Upgrade
|
| Free Cash Flow Margin | -9.44% | -23.57% | -4.71% | -18.02% | -60.57% | -17.29% | Upgrade
|
| EBITDA | -2,707 | -3,854 | -1,450 | -6,925 | 4,102 | -2,212 | Upgrade
|
| EBITDA Margin | -3.90% | -5.63% | -2.46% | -10.72% | 5.78% | -4.94% | Upgrade
|
| D&A For EBITDA | 2,911 | 2,859 | 1,961 | 1,830 | 1,526 | 1,120 | Upgrade
|
| EBIT | -5,618 | -6,712 | -3,411 | -8,756 | 2,576 | -3,332 | Upgrade
|
| EBIT Margin | -8.09% | -9.81% | -5.78% | -13.55% | 3.63% | -7.44% | Upgrade
|
| Advertising Expenses | - | 4,102 | 2,823 | 6,864 | 8,141 | 3,382 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.